A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS. (12th June 2019) - Shree, T.; Khodadoust, M.S.; Czerwinski, D.; Frank, M.J.; Hong, W.X.; Greenstein, R.; Long, S.; Martin, B.; Levy, R.